The firm has ten manufacturing sites and three drug development services sites, situated across France, Spain and Sweden, following the acquisition of CDMO, Synerlab Group and seven European manufacturing facilities from Recipharm last year. 

“There is a gap in the market for a niche-player, mid-sized CDMO that’s focused, agile, and dedicated to solving complex challenges, and we are well positioned to fulfill this unmet need,” says Meribel Pharma Solutions CEO, Bruce Vielle. “We have invested heavily in the latest technologies and expanded our capacity to meet the evolving needs of our customers. As a unified organisation, our foundations are built on quality and reliability.”

Inspired by the Alps

The name Meribel Pharma Solutions is inspired by the Meribel mountain range in the Alps. Located in the Three Valleys in France, the name symbolises the firm bringing together manufacturing excellence from across three countries, France, Spain and Sweden. It is also a nod to the firm’s commitment to helping customers navigate complex challenges and reach new heights in drug development and manufacturing, the company states.

Headquartered in the UK

Meribel Pharma Solutions is headquartered in the UK, and with 13 sites for manufacturing and drug development services located across France, Spain and Sweden. The company is backed by Blue Wolf Capital Partners, a middle-market private equity firm specializing in the industrial and healthcare sectors.